CA2098922A1 - Facteur de differentiation cholinergique neuronal - Google Patents

Facteur de differentiation cholinergique neuronal

Info

Publication number
CA2098922A1
CA2098922A1 CA002098922A CA2098922A CA2098922A1 CA 2098922 A1 CA2098922 A1 CA 2098922A1 CA 002098922 A CA002098922 A CA 002098922A CA 2098922 A CA2098922 A CA 2098922A CA 2098922 A1 CA2098922 A1 CA 2098922A1
Authority
CA
Canada
Prior art keywords
protein
neurons
expression
ncdf
vitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002098922A
Other languages
English (en)
Inventor
Mahrendra S. Rao
Story C. Landis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Case Western Reserve University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2098922A1 publication Critical patent/CA2098922A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002098922A 1990-12-21 1991-12-19 Facteur de differentiation cholinergique neuronal Abandoned CA2098922A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63243190A 1990-12-21 1990-12-21
US632,431 1990-12-21

Publications (1)

Publication Number Publication Date
CA2098922A1 true CA2098922A1 (fr) 1992-06-22

Family

ID=24535501

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002098922A Abandoned CA2098922A1 (fr) 1990-12-21 1991-12-19 Facteur de differentiation cholinergique neuronal

Country Status (5)

Country Link
EP (1) EP0563304A4 (fr)
JP (1) JPH06504285A (fr)
AU (1) AU9166291A (fr)
CA (1) CA2098922A1 (fr)
WO (1) WO1992011026A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105061A (en) * 1993-03-16 2000-11-21 Yeda Res & Dev Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof
JPH09503386A (ja) * 1993-09-01 1997-04-08 スタート テクノロジー パートナーシップ ニューロンの生存を促進するためのニューロン調節因子
US6472585B1 (en) 1994-04-25 2002-10-29 Genentech, Inc. Cardiotrophin-1 defective mouse
US5534615A (en) * 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US7258983B2 (en) 1994-04-25 2007-08-21 Genentech, Inc. Cardiotrophin-1 compositions and methods for the treatment of tumor
WO1995029237A1 (fr) * 1994-04-25 1995-11-02 Genentech, Inc. Cardiotrophine et ses utilisations
US7528112B2 (en) 2002-11-15 2009-05-05 Drexel University Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923696A (en) * 1987-05-04 1990-05-08 Baylor College Of Medicine Method to prepare a neurotrophic composition

Also Published As

Publication number Publication date
JPH06504285A (ja) 1994-05-19
EP0563304A4 (en) 1994-09-14
EP0563304A1 (fr) 1993-10-06
WO1992011026A1 (fr) 1992-07-09
AU9166291A (en) 1992-07-22

Similar Documents

Publication Publication Date Title
Rao et al. Characterization of a target-derived neuronal cholinergic differentiation factor
Schubert et al. Activin is a nerve cell survival molecule
US6291247B1 (en) Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activity
Meyer et al. Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF mRNA.
Takei et al. Neuronal survival factor from bovine brain is identical to neuron‐specific enolase
US5453361A (en) Method for producing biologically active human brain derived neurotrophic factor
US5250414A (en) Diagnostic methods using neurite growth regulatory factors
CA2250075C (fr) Procedes pour diagnostiquer et traiter la maladie d'alzheimer
Goodearl et al. ARIA is concentrated in the synaptic basal lamina of the developing chick neuromuscular junction.
Henderson et al. Localization of CNTF immunoreactivity to neurons and astroglia in the CNS
US6025333A (en) Treatment of CNS tumors with metalloprotease inhibitors
WO1995022344A1 (fr) Utilisation therapeutique de glycoproteines associees a la myeline (gam)
WO1998022499A9 (fr) Systeme de regulation de la croissance tumorale neuronale et neurale, anticorps destines a cet effet et utilisations de ceux-ci
WO1998022499A2 (fr) Systeme de regulation de la croissance tumorale neuronale et neurale, anticorps destines a cet effet et utilisations de ceux-ci
Halvorsen et al. Specific down-regulation of the alpha-bungarotoxin binding component on chick autonomic neurons by ciliary neuronotrophic factor
CA2098922A1 (fr) Facteur de differentiation cholinergique neuronal
Ebendal et al. Characterization of antibodies to synthetic nerve growth factor (NGF) and proNGF peptides
US7264808B2 (en) Synthetic peptide for neurological disorders
AU2004205659B2 (en) MNTF peptides and compositions and methods of use
EP0593516B1 (fr) Methodes de traitement de maladies des neurones moteurs utilisant des elements de la famille des molecules bdnf/nt-3/ngf
Prince et al. Expression of the F84. 1 glycoprotein in the spinal cord and cranial nerves of the developing rat
EP0258111A2 (fr) Facteur neuronotrophique
CH670451A5 (fr)
TANIGUCHI et al. Levels of neurokinin A, neurokinin B and substance P in rabbit iris sphincter muscle
US5644026A (en) Epitaxin, a cell motility factor

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 19971219